Cyclacel Pharmaceuticals' Series C Round

Cyclacel Pharmaceuticals raised a round of funding on June 12, 2001.

Cyclacel Pharmaceuticals is a biotechnology company developing novel cell-based immunotherapeutic treatments for cancer and infectious disease.…

Articles about Cyclacel Pharmaceuticals' Series C Round: